Equities research analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report issued to clients and investors on Friday. The firm set a "hold" rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.35 on Friday. The company has a market capitalization of $1.80 million, a PE ratio of -0.44 and a beta of 0.50. China Pharma has a one year low of $0.32 and a one year high of $4.15. The company's fifty day moving average price is $0.25 and its 200 day moving average price is $0.17.
Get
China Pharma
alerts:
China Pharma Company Profile
(Get Rating)
China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
Featured Articles
- Get a free copy of the StockNews.com research report on China Pharma (CPHI)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
VIP课程推荐
APP专享直播
热门推荐
收起
24小时滚动播报最新的财经资讯和视频，更多粉丝福利扫描二维码关注（sinafinance）
